{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:20:54Z","timestamp":1789215654710,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"DOI":"10.1093\/hmg\/ddh299","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T20:12:47Z","timestamp":1095883967000},"page":"2885-2892","source":"Crossref","is-referenced-by-count":41,"title":["Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes"],"prefix":"10.1093","volume":"13","author":[{"given":"Nicholas J.","family":"Bray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Jehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Moskvina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Dracheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahram","family":"Haroutunian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,9,22]]},"reference":[{"key":"key\n\t\t\t\t20171012131813_DDH299C1","unstructured":"Koch, S., Donarski, N., Goetze, K., Kreckel, M. Stuerenburg, H.J., Buhmann, C. and Beisiegel, U. (2001) Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res., 42, 1143\u20131151."},{"key":"key\n\t\t\t\t20171012131813_DDH299C2","unstructured":"Boerwinkle, E. and Utermann, G. (1988) Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am. J. Hum. Genet., 42, 104\u2013112."},{"key":"key\n\t\t\t\t20171012131813_DDH299C3","doi-asserted-by":"crossref","unstructured":"Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850\u2013852.","DOI":"10.1126\/science.8171342"},{"key":"key\n\t\t\t\t20171012131813_DDH299C4","doi-asserted-by":"crossref","unstructured":"Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron, 11, 575\u2013580.","DOI":"10.1016\/0896-6273(93)90070-8"},{"key":"key\n\t\t\t\t20171012131813_DDH299C5","doi-asserted-by":"crossref","unstructured":"Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA, 90, 1977\u20131981.","DOI":"10.1073\/pnas.90.5.1977"},{"key":"key\n\t\t\t\t20171012131813_DDH299C6","doi-asserted-by":"crossref","unstructured":"Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921\u2013930.","DOI":"10.1126\/science.8346443"},{"key":"key\n\t\t\t\t20171012131813_DDH299C7","doi-asserted-by":"crossref","unstructured":"Hyman, B.T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F. and Wallace, R. (1996) Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol., 40, 55\u201366.","DOI":"10.1002\/ana.410400111"},{"key":"key\n\t\t\t\t20171012131813_DDH299C8","doi-asserted-by":"crossref","unstructured":"Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J.C. and Goate, A. (1994) Protection against Alzheimer's disease with apoE epsilon 2. Lancet, 343, 1432\u20131433.","DOI":"10.1016\/S0140-6736(94)92557-7"},{"key":"key\n\t\t\t\t20171012131813_DDH299C9","doi-asserted-by":"crossref","unstructured":"Bales, K.R., Verina, T., Dodel, R.C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E.M., Little, S.P., Cummins, D.J. et\u00a0al. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet., 17, 263\u2013264.","DOI":"10.1038\/ng1197-263"},{"key":"key\n\t\t\t\t20171012131813_DDH299C10","doi-asserted-by":"crossref","unstructured":"Holtzman, D.M., Bales, K.R., Tenkova, T., Fagan, A.M., Parsadanian, M., Sartorius, L.J., Mackey, B., Olney, J., McKeel, D., Wozniak, D. and Paul, S.M. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 97, 2892\u20132897.","DOI":"10.1073\/pnas.050004797"},{"key":"key\n\t\t\t\t20171012131813_DDH299C11","doi-asserted-by":"crossref","unstructured":"Stengard, J.H., Clark, A.G., Weiss, K.M., Kardia, S., Nickerson, D.A., Salomaa, V., Ehnholm, C., Boerwinkle, E. and Sing, C.F. (2002) Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am. J. Hum. Genet., 71, 501\u2013517.","DOI":"10.1086\/342217"},{"key":"key\n\t\t\t\t20171012131813_DDH299C12","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Perez-Tur, J., Dupire, M.J., Galasko, D., Mann, D., Amouyel, P., Hardy, J., Delacourte, A. and Chartier-Harlin, M.C. (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet., 6, 2151\u20132154.","DOI":"10.1093\/hmg\/6.12.2151"},{"key":"key\n\t\t\t\t20171012131813_DDH299C13","doi-asserted-by":"crossref","unstructured":"Growdon, W.B., Cheung, B.S., Hyman, B.T. and Rebeck, G.W. (1999) Lack of allelic imbalance in APOE epsilon3\/4 brain mRNA expression in Alzheimer's disease. Neurosci. Lett., 272, 83\u201386.","DOI":"10.1016\/S0304-3940(99)00557-1"},{"key":"key\n\t\t\t\t20171012131813_DDH299C14","doi-asserted-by":"crossref","unstructured":"Bullido, M.J., Artiga, M.J., Recuero, M., Sastre, I., Garcia, M.A., Aldudo, J., Lendon, C., Han, S.W., Morris, J.C., Frank, A. et\u00a0al. (1998) Polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet., 18, 69\u201371.","DOI":"10.1038\/ng0198-69"},{"key":"key\n\t\t\t\t20171012131813_DDH299C15","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin, M.C. (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet., 7, 533\u2013540.","DOI":"10.1093\/hmg\/7.3.533"},{"key":"key\n\t\t\t\t20171012131813_DDH299C16","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Araria-Goumidi, L., Myllykangas, L., Ellis, C., Wang, J.C., Bullido, M.J., Harris, J.M., Artiga, M.J., Hernandez, D., Kwon, J.M. et\u00a0al. (2002) Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology, 59, 59\u201366.","DOI":"10.1212\/WNL.59.1.59"},{"key":"key\n\t\t\t\t20171012131813_DDH299C17","doi-asserted-by":"crossref","unstructured":"Artiga, M.J., Bullido, M.J., Sastre, I., Recuero, M., Garcia, M.A., Aldudo, J., Vazquez, J. and Valdivieso, F. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett., 421, 105\u2013108.","DOI":"10.1016\/S0014-5793(97)01543-3"},{"key":"key\n\t\t\t\t20171012131813_DDH299C18","doi-asserted-by":"crossref","unstructured":"Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. (2002) Allelic variation in human gene expression. Science, 297, 1143.","DOI":"10.1126\/science.1072545"},{"key":"key\n\t\t\t\t20171012131813_DDH299C19","doi-asserted-by":"crossref","unstructured":"Bray, N.J., Buckland, P.R., Williams, N.M., Williams, H.J., Norton, N., Owen, M.J. and O'Donovan, M.C. (2003) A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet., 73, 152\u2013161.","DOI":"10.1086\/376578"},{"key":"key\n\t\t\t\t20171012131813_DDH299C20","doi-asserted-by":"crossref","unstructured":"Yamagata, K., Urakami, K., Ikeda, K., Ji, Y., Adachi, Y., Arai, H., Sasaki, H., Sato, K. and Nakashima, K. (2001) High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 12, 57\u201362.","DOI":"10.1159\/000051236"},{"key":"key\n\t\t\t\t20171012131813_DDH299C21","doi-asserted-by":"crossref","unstructured":"Fukumoto, H., Ingelsson, M., Garevik, N., Wahlund, L.O., Nukina, N., Yaguchi, Y., Shibata, M., Hyman, B.T., Rebeck, G.W. and Irizarry, M.C. (2003) APOE epsilon 3\/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Exp. Neurol., 183, 249\u2013253.","DOI":"10.1016\/S0014-4886(03)00088-8"},{"key":"key\n\t\t\t\t20171012131813_DDH299C22","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Brousseau, T., Defosse, V., Evans, A., Arveiler, D., Ruidavets, J.B., Haas, B., Cambou, J.P., Luc, G., Ducimetiere, P. et\u00a0al. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations\u2014the ECTIM study. Hum. Mol. Genet., 9, 57\u201361.","DOI":"10.1093\/hmg\/9.1.57"},{"key":"key\n\t\t\t\t20171012131813_DDH299C23","doi-asserted-by":"crossref","unstructured":"Laws, S.M., Taddei, K., Martins, G., Paton, A., Fisher, C., Clarnette, R., Hallmayer, J., Brooks, W.S., Gandy, S.E. and Martins, R.N. (1999) The \u2212491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport, 10, 879\u2013882.","DOI":"10.1097\/00001756-199903170-00038"},{"key":"key\n\t\t\t\t20171012131813_DDH299C24","doi-asserted-by":"crossref","unstructured":"Laws, S.M., Hone, E., Taddei, K., Harper, C., Dean, B., McClean, C., Masters, C., Lautenschlager, N., Gandy, S.E. and Martins, R.N. (2002) Variation at the APOE \u2212491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatr., 7, 886\u2013890.","DOI":"10.1038\/sj.mp.4001097"},{"key":"key\n\t\t\t\t20171012131813_DDH299C25","unstructured":"Hixon, J.E. and Vernier, D.T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J. Lipid Res., 31, 1432\u20131433."},{"key":"key\n\t\t\t\t20171012131813_DDH299C26","doi-asserted-by":"crossref","unstructured":"Hoogendoorn, B., Norton, N., Kirov, G., Williams, N., Hamshere, M.L., Spurlock, G., Austin, J., Stephens, M.K., Buckland, P.R., Owen, M.J. and O'Donovan, M.C. (2000) Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum. Genet., 107, 488\u2013493.","DOI":"10.1007\/s004390000397"},{"key":"key\n\t\t\t\t20171012131813_DDH299C27","doi-asserted-by":"crossref","unstructured":"Zhao, H., Curtis, D. and Sham, P.C. (2000) Model-free analysis and permutation tests for allelic associations. Hum. Hered., 50, 133\u2013139.","DOI":"10.1159\/000022901"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/13\/22\/2885\/1676795\/ddh299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,5]],"date-time":"2018-08-05T16:23:21Z","timestamp":1533486201000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/13\/22\/2885\/610242\/Allelic-expression-of-APOE-in-human-brain-effects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,22]]},"references-count":27,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2004,9,22]]},"published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddh299","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11,15]]},"published":{"date-parts":[[2004,9,22]]}}}